Treating to Goal: A Clear Path to Patient-Centered Psoriasis Management
Target Audience
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Recognize the most relevant symptoms for individual patients to develop appropriate personalized treatment plans;
- Develop a shared decision-making strategy to guide treatment choices and measurable goals for your patients to improve outcomes;
- Describe the pathogenesis of psoriasis;
- Discuss the spectrum of available therapies and the evidence to support the development of personalized treatment plans;
- Identify and manage comorbidities utilizing a collaborative treatment approach with other disciplines.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
FACULTY
Associate Prof and Director of Inpatient Consultation and Dermatology
University of Michigan, Ann Arbor
Arthur C. Curtis Professor of Molecular Skin Immunology
Frances and Kenneth Eisenberg Emerging Scholar
Tabuman Medical Research Institute
Ann Arbor, MI
Senior Dermatologist
Pariser Dermatology
Professor
Eastern Virginia Medical School, Dept of Dermatology
Norfolk, VA
Senior Family Physician
Collegeville Family Practice
Medical Director
Ursinus College
Collegeville, PA
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!